Categories: Uncategorized

AV-Comparatives Releases 2024 Advanced Threat Protection Test Results for Enterprise Cybersecurity Solutions

Helping CISOs Select Top-Performing Cybersecurity Solutions with Rigorous Advanced Threat Protection Testing Results for 2024

Advanced Threat Protection Test 2024 

INNSBRUCK, Austria, Nov. 18, 2024 /PRNewswire/ — AV-Comparatives, a globally recognised independent organisation specialising in cybersecurity testing, is pleased to announce the results of its 2024 Advanced Threat Protection (ATP) Test for enterprise cybersecurity solutions. This comprehensive evaluation provides Chief Information Security Officers (CISOs) with critical insights into the efficacy of leading endpoint protection products against sophisticated, targeted cyber threats.

The full report of the Advanced Threat Protection Test 2024 – Enterprise is available at: https://www.av-comparatives.org/tests/advanced-threat-protection-test-2024-enterprise/ 

- Advertisement -

The ATP Test rigorously assesses each product’s ability to defend against advanced persistent threats (APTs), which are complex, multi-stage attacks aimed at specific organisations. By simulating real-world attack scenarios, the test offers an objective measure of how well security solutions can prevent breaches that could lead to significant financial and reputational damage.

The 2024 evaluation included the following enterprise security products:

  • Avast Ultimate Business Security 24.8
  • Bitdefender GravityZone Business Security Premium 7.9
  • CrowdStrike Falcon Pro 7.16
  • ESET PROTECT Entry with ESET PROTECT Cloud 11.1
  • Kaspersky Endpoint Security for Business – Select, with KSC 12.6
  • NetSecurity ThreatResponder 3.5

Each of these solutions demonstrated robust protection capabilities, successfully blocking a significant number of advanced attacks. Notably, all six products achieved AV-Comparatives’ prestigious ATP Enterprise Certification, underscoring their effectiveness in safeguarding enterprise environments against sophisticated threats.

For CISOs and decision-makers, these results serve as a valuable resource for selecting security solutions that align with their organisation’s specific needs. The detailed findings offer a clear comparison of each product’s strengths, facilitating informed decisions to enhance organisational cybersecurity postures.

AV-Comparatives remains committed to providing transparent, scientifically rigorous evaluations of cybersecurity products. By delivering unbiased assessments, we empower organisations to make informed choices in an ever-evolving threat landscape.

- Advertisement -

The full report of the Advanced Threat Protection Test 2024 – Enterprise is available at: https://www.av-comparatives.org/tests/advanced-threat-protection-test-2024-enterprise/

Methodology

AV-Comparatives used five different Initial Access Phases, distributed among the 15 test cases, mapped to the MITRE ATT&CK Matrix (c)

- Advertisement -

Trusted Relationship: “Adversaries may breach or otherwise leverage organizations who have access to intended victims. Access through trusted third-party relationship exploits an existing connection that may not be protected or receives less scrutiny than standard mechanisms of gaining access to a network.”

Valid accounts: “Adversaries may steal the credentials of a specific user or service account using Credential Access techniques or capture credentials earlier in their reconnaissance process through social engineering […].”

Replication Through Removable Media: “Adversaries may move onto systems […] by copying malware to removable media […] and renaming it to look like a legitimate file to trick users into executing it on a separate system. […]”

Phishing: Spearphishing Attachment: “Spearphishing attachment is […] employs the use of malware attached to an email. […]”

Phishing: Spearphishing Link: “Spearphishing with a link […] employs the use of links to download malware contained in email […].”

The complete methodology can be found here: https://www.av-comparatives.org/tests/advanced-threat-protection-test-2024-enterprise/ 

Business Security Test August-September 2024 – Factsheet

Read also the latest Business Security Factsheet for August-September 2024, containing the results of the Business Malware Protection Test (September) and Business Real-World Protection Test (August-September). The full report, including the Performance Test and product reviews, will be released in December.

Link to Testreport: https://www.av-comparatives.org/tests/business-security-test-august-september-2024-factsheet/

Tested  Products:

  • Avast Ultimate Business Security
  • Bitdefender GravityZone Business Security Premium
  • CISCO Secure Endpoint Essentials
  • CrowdStrike Falcon Pro
  • Elastic Security
  • ESET PROTECT Entry with ESET PROTECT Cloud
  • G Data Endpoint Protection Business
  • K7 On-Premises Enterprise Security Advanced
  • Kaspersky Endpoint Security for Business – Select, with KSC
  • Microsoft Defender Antivirus with Microsoft Endpoint Manager
  • NetSecurity ThreatResponder
  • Rapid7 InsightIDR
  • SenseOn Platform with EPP
  • Sophos Intercept X Advanced
  • Trellix Endpoint Security (ENS)
  • VIPRE Endpoint Detection and Response
  • VMware Carbon Black Cloud Endpoint Standard

Details:

  • Bitdefender, Sophos, Cisco, and ESET all achieved exceptional scores, with Bitdefender delivering a flawless performance in both the Real-World Protection and Malware Protection tests.
  • Kaspersky, Trellix, VIPRE, and G Data also maintained strong protection rates with no false alarms on critical business software.
  • Avast, CrowdStrike, K7, and Microsoft demonstrated robust security features while maintaining a balance between protection and low system impact.
  • Other top performers include Elastic, NetSecurity, Rapid7, SenseOn, and VMware, all of which delivered competitive results, meeting or exceeding the high standards required for certification.

Across the board, these products ensured a high level of security for enterprise environments, with zero false positives on common business software. The tests were conducted under real-world conditions to reflect the cybersecurity challenges and demands faced by modern enterprises.

Peter Stelzhammer, co-founder AV-Comparatives: “Our rigorous testing process highlights the high quality of enterprise security solutions available today. These products offer businesses both the strong protection they need and the performance they demand.”

About AV-Comparatives: AV-Comparatives is a globally recognised, independent organisation offering systematic testing to examine the efficacy of cybersecurity solutions. Using one of the most comprehensive and rigorous testing methodologies, AV-Comparatives provides businesses and consumers with unbiased, transparent, and reliable test results.

AV-Comparatives – Where Security Meets Trust – Unbiased. Transparent. Trusted.

Contact:  Peter Stelzhammer, media@av-comparatives.org, +43512287788  

Photo – https://mma.prnewswire.com/media/2560264/AV_Comparatives_1.jpg
Photo – https://mma.prnewswire.com/media/2560265/AV_Comparatives_2.jpg
Logo – https://mma.prnewswire.com/media/2257205/5032302/Logo.jpg

 

 

 

 

View original content:https://www.prnewswire.co.uk/news-releases/av-comparatives-releases-2024-advanced-threat-protection-test-results-for-enterprise-cybersecurity-solutions-302308342.html

Recent Posts

KFSHRC Madinahs Virtual Clinics Wins Award at PX Congress

RIYADH, Saudi Arabia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research…

7 hours ago

IBA Business Update Third Quarter 2024

Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in…

7 hours ago

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR…

7 hours ago

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in…

7 hours ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Revuforj (revumenib)

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy,…

7 hours ago

Las Vegas Unveils Exclusive Entertainment, Packages and More for Race Week 2024

Destination Revving up This Year’s Excitement with Top-Tier Entertainment, Luxurious Trackside Experiences and Celebrations like…

10 hours ago